Chronic myelomonocytic leukemia
Ontology highlight
ABSTRACT: Chronic myelomonocytic leukemia is an aggressive hematological malignancy with dismal outcomes, with the pCMML subtype in particular having median OS of <2 years and high rates of AML transformation (Patnaik et al., 2014). Given limited therapeutic options for affected patients, we carried out this study to define the genetic and epigenetic landscape of pCMML and identify therapies that could modify disease biology.
PROVIDER: EGAS00001005107 | EGA |
REPOSITORIES: EGA
ACCESS DATA